Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Open accessThe DOI matches its Crossref record; 359 of the 366 references it cites were found in a registry or an index; 136 of the 423 sources its claims cite were checked for support.
Abstract
Consensus report providing evidence-based guidance on individualized nutrition therapy for adults with diabetes or prediabetes.
Overview
CoChat Summary
TL;DR
This ADA consensus report provides evidence-based guidance for individualizing nutrition therapy in adults with diabetes or prediabetes, emphasizing medical nutrition therapy (MNT) by a registered dietitian nutritionist, weight management, and flexible eating patterns. It concludes no single eating plan fits all and that reducing overall carbohydrate intake has the most evidence for improving glycemia, while many areas need further research.
Key findings
- MNT provided by RDNs improves A1C, with absolute decreases up to 2.0% in type 2 diabetes and up to 1.9% in type 1 diabetes at 3–6 months; ongoing MNT support helps maintain glycemic improvements.
- Diabetes prevention: the DPP intensive lifestyle intervention reduced type 2 diabetes incidence by 58% over 3 years; sustained reductions were 43% at 20 years (Da Qing), 43% at 7 years (Finnish DPS), and 34% at 10 years and 27% at 15 years (DPPOS).
- Weight loss goals: 5% weight loss is recommended for clinical benefit in type 2 diabetes, with optimal outcomes at 15% or more; the prediabetes goal is 7–10%. DiRECT showed 46% diabetes remission at 1 year; Look AHEAD intensive lifestyle yielded at least partial remission in 11.5% vs 2% in control.
- Eating patterns: no ideal macronutrient distribution applies to all; reducing overall carbohydrate intake has the most evidence for improving glycemia, and low- or very low-carbohydrate plans are viable for select adults with type 2 diabetes. PREDIMED’s Mediterranean-style eating pattern was associated with 30% lower relative risk of type 2 diabetes; vegetarian/vegan patterns reduced A1C by an average of 0.3–0.4%.
Methods
- Expert consensus process: authors were selected after a national call; the 2014 ADA nutrition position statement was used as a starting point; a PubMed search covered English studies published 1 January 2014–28 February 2018 in nonhospitalized adults with prediabetes, type 1 diabetes, or type 2 diabetes, emphasizing RCTs, systematic reviews, and meta-analyses of RCTs, with meal studies allowed for the insulin dosing section.
- Consensus was reached through an in-person meeting, monthly teleconferences between February and November 2018, and additional calls, email, and web-based collaboration between November 2018 and January 2019; the report was peer reviewed and the recommendations are the authors’ informed expert opinions after consensus.
Limitations
- The paper states that the recommendations are informed expert opinions after consensus; few long-term (2 years or longer) randomized trials have been conducted of dietary patterns; knowledge gaps remain and further research is needed, including on personalized nutrition, type 1 diabetes, and comparative eating patterns.
- Evident from the text: the literature search was limited to English-language studies from a defined 2014–2018 window and was not a formal systematic review or meta-analysis; many conclusions rest on mixed or inconclusive evidence, and the report notes that large, well-conducted nutrition trials continue to lag far behind other areas of diabetes research.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
87 Valid · 9 Not valid · 105 Not checked · 29 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cost-effectiveness of lifestyle interventions and MNT for the prevention and management of diabetes has been documented in multiple studies (12,17, 24,25).”
What the sources say
- Partly supportedcites [12] 12. Davidson P, Ross T, Castor C. Academy of Nutrition and Dietetics: Revised 2017 Standards of Practice and Standards of Professional Performance for Registered Dietitian Nutritionists (Competent, Pro fi cient, and Expert) in Diabetes Care. J Acad Nutr Diet 2018;118:932 -946. e48 sourceExperimental — accuracy not yet measured
The Overview describes evidence that lifestyle changes can prevent type 2 diabetes and that MNT improves clinical outcomes. The standards in Additional information call for programs that deliver cost-effective diabetes care and education, but the paper does not report multiple studies documenting the cost-effectiveness of lifestyle interventions and MNT specifically. The indexed passages provide no page number for these sections. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [17] 17. Briggs Early K, Stanley K. Position of the Academy of Nutrition and Dietetics: the role of medical nutrition therapy and registered dietitian nutritionists in the prevention and treatment of prediabetes and type 2 diabetes. J Acad Nutr Diet 2018;118:343 -353 source
- Not checked — no full text of the sourcecites [24] 24. Sun Y, You W, Almeida F, Estabrooks P, Davy B. The effectiveness and cost of lifestyle interventions including nutrition education for diabetes prevention: a systematic review and meta-analysis. J Acad Nutr Diet 2017;117:404 -421.e36 source
- Not matchedcites [25] 25. AcademyofNutritionandDieteticsEvidence Analysis Library. MNT: cost effectiveness, costbenefi t, or economic savings of MNT (2009) [Internet]. Available from https://www.andeal. org/topic.cfm?cat=4085&conclusion\_statement\_ id=251001. Accessed 2 October 2018
We searched by its title and found no matching paper.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The strongest evidence for type 2 diabetes prevention comes from several studies, including the DPP (26 -28).”
What the sources say
- Not checked — no full text of the sourcecites [26] 26. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393 -403 source
- Supportedcites [27] 27. Lindstr¨ om J, Louheranta A, Mannelin M, et al.; Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003;26: 3230 -3236 source
The opening section (labeled “T”; page not provided) describes the DPS as one of the first randomized controlled studies to show that lifestyle intervention can prevent type 2 diabetes. It also says the DPP reproduced its 58% risk reduction, supporting the claim that both studies provide strong prevention evidence. (LLM, conf=0.90)
- Supportedcites [28] 28. Knowler WC, Fowler SE, Hamman RF, et al.; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677 -1686 source
The Introduction identifies the DPP as a randomised trial in which lifestyle intervention and metformin prevented or delayed type 2 diabetes in high-risk adults. The Discussion says the DPP and other clinical trials established the feasibility of interrupting worsening hyperglycaemia, supporting the citing sentence’s broad characterization of the evidence. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The regular intake of suf fi cient dietary fi ber is associated with lower all-cause mortalityin people withdiabetes (51,52).”
What the sources say
- Not checked — no full text of the sourcecites [51] 51. He M, van Dam RM, Rimm E, Hu FB, Qi L. Whole-grain, cereal fi ber, bran, and germ intake and the risks of all-cause and cardiovascular disease-speci fi c mortality among women with type 2 diabetes mellitus. Circulation 2010;121: 2162 -2168 source
- Supportedcites [52] 52. Burger KNJ, Beulens JWJ, van der Schouw YT, et al. Dietary fi ber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus. PLoS One 2012;7:e43127 source
The Results report that higher dietary fiber intake was associated with lower all-cause mortality in individuals with diabetes (adjusted HR per SD increase, 0.83; 95% CI, 0.75–0.91). The Discussion identifies this as the study’s main finding. The paper evaluates higher intake rather than defining a specific threshold for ‘sufficient’ intake. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Other metaanalyses of observational studies have not shown an inverse relationship with full-fat dairy intake and diabetes risk (72,73).”
What the sources say
- Not checked — no full text of the sourcecites [72] 72. Gijsbers L, Ding EL, Malik VS, de Goede J, Geleijnse JM, Soedamah-Muthu SS. Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies. Am J Clin Nutr 2016;103:1111 -1124 source
- Could not verifycites [73] 73. Schwingshackl L, Chaimani A, Hoffmann G, Schwedhelm C, Boeing H. A network meta-analysis on the comparative ef fi cacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol 2018;33:157 -170 sourceExperimental — accuracy not yet measured
The Results describe a meta-analysis of dietary trials in patients who already have type 2 diabetes, not observational studies of diabetes risk. The supplied References name a separate meta-analysis of food groups and diabetes risk, but our copy does not report what it found about full-fat dairy. Searches for full-fat dairy and observational evidence of an inverse association found no passage addressing the claim. (LLM, conf=0.74)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The most robust research available related to eating patterns for prediabetes or type 2 diabetes prevention are Mediterranean-style, low-fat, or lowcarbohydrate eating plans (26,69,74,75).”
What the sources say
- Not checked — no full text of the sourcecites [26] 26. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393 -403 source
- Not matchedcites [69] 69. Salas-Salvad´ o J, Bull´ o M, Estruch R, et al. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. Ann Intern Med 2014;160:1 -10
We searched by its title and found no matching paper.
- Partly supportedcites [74] 74. Tuomilehto J, Lindstr¨ omJ, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343 -1350 sourceExperimental — accuracy not yet measured
The Study Design describes a low-fat dietary goal as part of an intervention that also included weight loss, more fiber, and exercise. The Discussion reports reduced diabetes incidence with comprehensive lifestyle changes and says the study did not separate the effects of diet and exercise. It does not compare eating plans or establish which have the most robust evidence; Mediterranean-style and low-carbohydrate plans are not supported by this source. (LLM, conf=0.86)
- Could not verifycites [75] 75. Stentz FB, Brewer A, Wan J, et al. Remission of pre-diabetes to normal glucose tolerance in obese adults with high protein versus high carbohydrate diet: randomized control trial. BMJ Open Diabetes Res Care 2016;4:e000258 sourceExperimental — accuracy not yet measured
The Introduction discusses lifestyle changes and mentions low-carbohydrate diets among approaches studied for weight loss, while the Conclusions focus on the trial’s high-protein diet for remission of prediabetes. Our copy does not assess which eating patterns have the most robust evidence for prevention or identify Mediterranean-style, low-fat, and low-carbohydrate plans as that group (searched for those patterns and comparative evidence). (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
130 more claims · 48 with their cited sources checked
Create a free account to see all 230 claims and to verify the 11 references still open.
- It may state two separate claims as one. 79
- Probably not a substantial claim. 16
- The quote only partly states this claim. 4
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These 3 food groups are consistently recommended by national and international public health organizations based on extensive evidence of cardiovascular benefits of fiber, antioxidants, and the vitamins and minerals characteristic of those food groups (2, 12–15).”
From Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the Interventional Keto-Med Randomized Crossover Trial. (2022) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Collectively, these potential harms likely relate to avoiding legumes, fruits, and whole, intact grains on the WFKD, and temper enthusiasm for avoiding these food groups, which is consistently recommended by national and international public health organizations (2, 12–15).”
From Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the Interventional Keto-Med Randomized Crossover Trial. (2022) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To achieve ketosis, very-low-carbohydrate diets, and to some extent low-carbohydrate diets, require the elimination or severe restriction of legumes, fruits, starchy vegetables, and grains (including whole grains), despite the established general health benefits of these foods and food groups [30, 32, 33].”
From Benefits of low carbohydrate diets: a settled question or still controversial? (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For diabetes management, there is increasing evidence that adults with prediabetes or diabetes benefit from reduced carbohydrate diets by improving glycemia and some cardiometabolic risk factors [30, 78].”
From Benefits of low carbohydrate diets: a settled question or still controversial? (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Research supports diabetes care and education specialists (DCES), including nurses, registered dietitian nutritionists (RDNs), and pharmacists as providers of DSMES who may also tailor curriculum to the person's needs (68)(69)(70).”
From 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023 (2023) · cites this paper as [70]
Experimental — accuracy not yet measured
39 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Whatistherole of fat in the prevention of type 2 diabetes? · p. 6
“Other metaanalyses of observational studies have not shown an inverse relationship with full-fat dairy intake and diabetes risk (72,73).”
§ References · p. 18
“73. Schwingshackl L, Chaimani A, Hoffmann G, Schwedhelm C, Boeing H. A network meta-analysis on the comparative ef fi cacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus.”
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Personalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929 · cited 1×
“wide interpersonal variability in blood glucose response to standardized meals that could be predicted by clinical and microbiome profiles (332).”
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Research works printed but not linked: 5
- 227. Franz MJ, Evert AB (Eds.). American Diabetes Association Guide to Nutrition Therapy for Diabetes. 3rd edition. Alexandria, VA, American Diabetes Association, 2017. Available from http://www.shopdiabetes.org/2283-AmericanDiabetes-Association-Guide-to-Nutrition-Therapyfor-Diabetes-3rd-Edition.aspx. Accessed 2 October 2018
- 255. TariqSH.Herbaltherapies.ClinGeriatrMed 2004;20:237 -257
- 304. ASCEND Study Collaborative Group; Bowman L, Mafham M, Wallendszus K, et al. Effects of n-3 fatty acid supplementsindiabetesmellitus. NEnglJ Med 2018;379:1540 -1550
- 311. World Health Organization. Guideline: Sodium Intake for Adults and Children [Internet], 2012. Available from http://www.ncbi.nlm.nih. gov/books/NBK133309/.Accessed20November 2018
- 312. Institute of Medicine Committee on Strategies to Reduce Sodium Intake. Strategies to Reduce Sodium Intake in the United States [Internet]. Henney JE, Taylor CL, Boon CS, Eds. Washington, DC, National Academies Press, 2010. Available from http://www.ncbi.nlm.nih. gov/books/NBK50956/. Accessed 20 November 2018
Cited by
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
“The need for additional dietary advice should be reevaluated over time (310).”
BackgroundKDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
“The need for additional dietary advice should be reevaluated over time [310].”
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
“Since this is highly variable between individuals, postprandial glucose measurements for up to 3 h or more may be needed to determine initial dose adjustments (134).”
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationPowers, M. A., Bardsley, J. K., Cypress, M., Funnell, M. M., Harms, D., Hess-Fischl, A., Hooks, B., Isaacs, D., Mandel, E. D., Maryniuk, M. D., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0023 · Cited by 500
Self-citationDietary Strategies for Metabolic Syndrome: A Comprehensive Review
Castro-Barquero, S., Ruiz-León, A. M., Sierra-Pérez, M., Estruch, R., & Casas, R. (2020) · Nutrients · doi:10.3390/nu12102983 · Cited by 482
“Low CH diets and very low CH diets (ketogenic diets) n <50% kcal/d from carbohydrates and <10% kcal/d from CH in ketogenic diets n High protein (20–30% kcal/d) n High fat intake (30–70% kcal/d) Weight-loss and weight-loss maintenance [49–52] Reduction of DBP [52] Reduction of LDL-c and triglycerides levels [49–51] Inc…”
BackgroundGoldenberg, J. Z., Day, A., Brinkworth, G. D., Sato, J., Yamada, S., Jönsson, T., Beardsley, J., Johnson, J. A., Thabane, L., & Johnston, B. C. (2021) · BMJ · doi:10.1136/bmj.m4743 · Cited by 428
International tables of glycemic index and glycemic load values 2021: a systematic review
Atkinson, F. S., Brand-Miller, J. C., Foster-Powell, K., Buyken, A. E., & Goletzke, J. (2021) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab233 · Cited by 420
“However, over time, the WHO (5), International Diabetes Federation (6), American Diabetes Association (7), Diabetes UK (8), and Diabetes Canada (9) have given it qualified support.”
BackgroundKirkpatrick, C. F., Bolick, J. P., Kris-Etherton, P. M., Sikand, G., Aspry, K. E., Soffer, D. E., Willard, K.-E., & Maki, K. C. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2019.08.003 · Cited by 390
“With VLCHF/KDs, gastrointestinal complaints tend to be the most common adverse effects, including constipation, nausea, and abdominal pain, which are experienced in the first few weeks.13 Some individuals may experience symptoms described as the ‘‘keto flu’’ within 2 to 4 days of beginning a VLCHF/KD, which may occur…”
BackgroundInfluentialHolt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s005 · Cited by 362
“For people with type 2 diabetes, low-carbohydrate and very-low-carbohydrate eating patterns in particular have been found to reduce A1C and the need for antihyperglycemic medications (70,130,143,163 – 165).”
InfluentialAmerican Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s005 · Cited by 339
“To support weight loss and improve A1C, cardiovascular disease (CVD) risk factors, and well-being in adults with overweight/ obesity and prediabetes or diabetes, MNT and DSMES services should include an individualized eating plan in a format that results in an energy deficit in combination with enhanced physical activ…”
BackgroundInfluentialCusi, K., Abdelmalek, M. F., Apovian, C. M., Balapattabi, K., Bannuru, R. R., Barb, D., Bardsley, J. K., Beverly, E. A., Corbin, K. D., ElSayed, N. A., et al. (2025) · Diabetes Care · doi:10.2337/dci24-0094 · Cited by 332
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s005 · Cited by 445
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Eichorst, B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s005 · Cited by 305
Self-citationAmerican Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s005 · Cited by 299
“A variety of eating patterns are acceptable for the management of diabetes (46,66,68,69).”
BackgroundInfluentialAmerican Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Beverly, E. A., Bruemmer, D., Collins, B. S., Darville, A., Ekhlaspour, L., Hassanein, M., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s005 · Cited by 285
An Effective Model of Diabetes Care and Education: The ADCES7 Self-Care Behaviors™
Association of Diabetes Care and Education Specialists, & Kolb, L. (2021) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721720978154 · Cited by 246
“Strategies such as carbohydrate counting, the plate method, and weight management exchange lists have been effective in achieving cardiometabolic and weight management goals.(64,65) These techniques empower people to make choices based on their food preferences while maintaining an energy intake and macronutrient comp…”
MethodAmerican Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s008 · Cited by 244
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s008 · Cited by 244
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s008 · Cited by 236
Diabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
Watanabe, M., Tozzi, R., Risi, R., Tuccinardi, D., Mariani, S., Basciani, S., Spera, G., Lubrano, C., & Gnessi, L. (2020) · Obesity Reviews · doi:10.1111/obr.13024 · Cited by 215
“Moreover, the American Diabetes Association has also confirmed the effectiveness of LCDs in reducing weight, improving blood glucose and lipids in patients with type 2 diabetes mellitus (T2DM).(25) For the purpose of a correct pathophysiological understanding of nutritional therapies, it appears necessary to clearly d…”
BackgroundChiavaroli, L., Lee, D., Ahmed, A., Cheung, A., Khan, T. A., Blanco, S., Mejia, Mirrahimi, A., Jenkins, D. J. A., Livesey, G., et al. (2021) · BMJ · doi:10.1136/bmj.n1651 · Cited by 215
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s008 · Cited by 213
Churuangsuk, C., Hall, J., Reynolds, A., Griffin, S. J., Combet, E., & Lean, M. E. J. (2022) · Diabetologia · doi:10.1007/s00125-021-05577-2 · Cited by 204
“Although all diet types are similarly effective for weight control, health risks were not systematically reported across the studies, and could differ [72].”
BackgroundBriggs Early, K., & Stanley, K. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.11.021 · Cited by 203
3. Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s003 · Cited by 200
“ing patterns, preferences, and metabolic goals (10).”
Background3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s003 · Cited by 204
Papakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199
Zhang, Y., Tan, H., Tang, J., Li, J., Chong, W., Hai, Y., Feng, Y., Lunsford, L. D., Xu, P., Jia, D., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1708 · Cited by 195
“The statement does not recommend the routine use of vitamin D ormultivitamins for improving glycemia in people with diabetes or prediabetes due to a lack of evidence (48).”
Background2022 National standards for diabetes self-management education and support
Davis, J., Fischl, A. H., Beck, J., Browning, L., Carter, A., Condon, J. E., Dennison, M., Francis, T., Hughes, P. J., Jaime, S., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2396 · Cited by 191
Self-citationAn Effective Model of Diabetes Care and Education: Revising the AADE7 Self-Care Behaviors ®
American Association of Diabetes Educators (2020) · The Diabetes Educator · doi:10.1177/0145721719894903 · Cited by 184
“Strategies such as carbohydrate counting, the plate method, and weight management exchange lists have been effective in achieving cardiometabolic and weight management goals.(64,65) These techniques empower people to make choices based on their food preferences, while maintaining an energy intake and macronutrient com…”
MethodAssociation of Socioeconomic and Geographic Factors With Diet Quality in US Adults
McCullough, M. L., Chantaprasopsuk, S., Islami, F., Rees-Punia, E., Um, C. Y., Wang, Y., Leach, C. R., Sullivan, K. R., & Patel, A. V. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.16406 · Cited by 183
Ezpeleta, M., Gabel, K., Cienfuegos, S., Kalam, F., Lin, S., Pavlou, V., Song, Z., Haus, J. M., Koppe, S., Alexandria, S. J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.001 · Cited by 181
Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus
Kumar, S., Behl, T., Sachdeva, M., Sehgal, A., Kumari, S., Kumar, A., Kaur, G., Yadav, H. N., & Bungau, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118661 · Cited by 173
Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era
Akil, A. A.-S., Yassin, E., Al-Maraghi, A., Aliyev, E., Al-Malki, K., & Fakhro, K. A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02778-6 · Cited by 168
“Reported HbA1C from medical nutrition therapy (MNT) decreases are similar or greater than what would be expected with currently available pharmacologic therapies for T1D [206].”
Background2022 National standards for diabetes self-management education and support
Davis, J., Fischl, A. H., Beck, J., Browning, L., Carter, A., Condon, J. E., Dennison, M., Francis, T., Hughes, P. J., Jaime, S., et al. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106211072203 · Cited by 169
Self-citationBoutari, C., DeMarsilis, A., & Mantzoros, C. S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110773 · Cited by 161
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s003 · Cited by 162
“Based on intervention trials, a variety of eating patterns may be appropriate for patients with prediabetes (10), including Mediterranean (11–13) and low-calorie, low-fat eating patterns (8).”
BackgroundAmerican Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s008 · Cited by 158
Chrono-nutrition for the prevention and treatment of obesity and type 2 diabetes: from mice to men
Hawley, J. A., Sassone‐Corsi, P., & Zierath, J. R. (2020) · Diabetologia · doi:10.1007/s00125-020-05238-w · Cited by 170
“Support for the comparative benefits of different eating patterns in individuals with type 2 diabetes is, at best, weak, with current evidence suggesting that there is not an ideal contribution from any macronutrient to daily energy requirements for all individuals with, or at risk for diabetes [12].”
BackgroundPavlou, V., Cienfuegos, S., Lin, S., Ezpeleta, M., Ready, K., Corapi, S., Wu, J., Lopez, J., Gabel, K., Tussing-Humphreys, L., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.39337 · Cited by 156
Gardner, C. D., Landry, M. J., Perelman, D., Petlura, C., Durand, L. R., Aronica, L., Crimarco, A., Cunanan, K. M., Chang, A., Dant, C. C., et al. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac154 · Cited by 151
“Our study is unique in comparing 2 low-carb diets—the well-formulated ketogenic diet (WFKD) and the Mediterraneanplus diet (Med-Plus)—that both incorporate 3 key nutrition messages endorsed by diabetes organizations (1, 2): including nonstarchy vegetables, restricting added sugars, and limiting refined grains.”
BackgroundResultSelf-citationRed and Processed Meats and Health Risks: How Strong Is the Evidence?
Qian, F., Riddle, M. C., Wylie‐Rosett, J., & Hu, F. B. (2020) · Diabetes Care · doi:10.2337/dci19-0063 · Cited by 190
“For the prevention and management of diabetes and other chronic diseases, it is important to follow current nutritional recommendations by the American Diabetes Association (15) and other professional and governmental organizations that allow for personalized choices but also emphasize dietary patterns high in minimal…”
BackgroundInfluentialMetabolically healthy obesity: what–s in a name?
Magkos, F. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz133 · Cited by 160
Diagnosis and Treatment of Type 2 Diabetes in Adults: A Review
Kalyani, R. R., Neumiller, J. J., Maruthur, N. M., & Wexler, D. J. (2025) · JAMA · doi:10.1001/jama.2025.5956 · Cited by 204
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s003 · Cited by 144
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s003 · Cited by 144
Nadolsky, K., Garvey, W. T., Agarwal, M., Bonnecaze, A., Burguera, B., Chaplin, M. D., Griebeler, M. L., Harris, S. R., Schellinger, J. N., Simonetti, J., et al. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.017 · Cited by 141
Self-citationLin, S., Cienfuegos, S., Ezpeleta, M., Gabel, K., Pavlou, V., Mulas, A., Chakos, K., McStay, M., Wu, J., Tussing-Humphreys, L., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0052 · Cited by 141
“8) Mean waist circumference (SD), cm 109 (13) 110 (14) 110 (13) Mean height (SD), cm 164 (9) 166 (9) 165 (7) Mean BMI (SD), kg/m(2) 37 (6) 37 (5) 38 (5)”
BackgroundInfluentialRen, M., Zhang, H., Qi, J., Hu, A., Jiang, Q., Hou, Y., Feng, Q., Ojo, O., & Wang, X. (2020) · Nutrients · doi:10.3390/nu12103036 · Cited by 139
“According to the energy supply ratio of carbohydrates, it can be divided into two modes: very low LCD (<26%), LCD (26~45%) [11].”
BackgroundAnnan, S. F., Higgins, L. A., Jelleryd, E., Hannon, T., Rose, S., Salis, S., Baptista, J., Chinchilla, P., & Marcovecchio, M. L. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13429 · Cited by 143
“(MUFA) and polyunsaturated fatty acids (PUFA) can be used as substitutes to improve the lipid profile (5).”
BackgroundInfluentialTeong, X., Liu, K., Vincent, A., Bensalem, J., Liu, B., Hattersley, K., Zhao, L.-J., Feinle-Bisset, C., Sargeant, T., Wittert, G., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02287-7 · Cited by 113
The Ketogenic Diet: Evidence for Optimism but High-Quality Research Needed
Ludwig, D. S. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxz308 · Cited by 133
“have been shown to reduce [Hb]A1C [glycated hemoglobin] and the need for antihyperglycemic medications” (22).”
BackgroundAmerican Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s003 · Cited by 132
“ate for patients with prediabetes (10),”
Kelly, T., Unwin, D., & Finucane, F. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17072557 · Cited by 128
“International consensus guidelines on the dietary management of type 2 diabetes now endorse carbohydrate restriction as a legitimate therapeutic strategy [19,24,25].”
BackgroundNovel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
Angelidi, A. M., Belanger, M. J., Kokkinos, A., Koliaki, C. C., & Mantzoros, C. S. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab034 · Cited by 128
Sodium Intake and Heart Failure
Patel, Y. R., & Joseph, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249474 · Cited by 156
“2019, American Diabetic Association [7] <2.”
Zeng, X.-F., Varady, K. A., Wang, X.-D., Targher, G., Byrne, C. D., Tayyem, R., Latella, G., Bergheim, I., Valenzuela, R., George, J., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156028 · Cited by 124
Powers, M. A., Bardsley, J. K., Cypress, M., Funnell, M. M., Harms, D., Hess-Fischl, A., Hooks, B., Isaacs, D., Mandel, E. D., Maryniuk, M. D., et al. (2020) · The Diabetes Educator · doi:10.1177/0145721720930959 · Cited by 123
Self-citationNutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges
Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F. (2021) · Nutrients · doi:10.3390/nu13082748 · Cited by 116
“The foundation of medical nutrition therapy (MNT) of T2D is to achieve glucose, lipids, and blood pressure within the target range to prevent, delay or manage microvascular and macrovascular complications [36,37].”
BackgroundKahleova, H., Salas-Salvadó, J., Rahelić, D., Kendall, C. W., Rembert, E., & Sievenpiper, J. L. (2019) · Nutrients · doi:10.3390/nu11092209 · Cited by 114
“Currently, the Mediterranean, DASH, and vegetarian dietary patterns are all recommended as healthy by the 2015–2020 Dietary Guidelines for Americans [58] and are included in the American Diabetes Association’s clinical practice guidelines for people with diabetes or prediabetes [59].”
BackgroundNew horizons. A new paradigm for treating to target with second-generation obesity medications
Garvey, W. T. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab848 · Cited by 110
“In patients with ABCD and prediabetes or metabolic syndrome, 10% weight loss is maximally effective for preventing progression to overt diabetes (5,12); in patients with T2D, the more weight loss the better where weight loss of >5% to 15% or more provides progressive improvements in HbA1c, blood pressure, and lipids (…”
BackgroundSelf-citationThe emergence of obesity in type 1 diabetes
Kueh, M. T. W., Chew, N. W. S., Al-Ozairi, E., & le Roux, C. W. (2024) · International Journal of Obesity · doi:10.1038/s41366-023-01429-8 · Cited by 111
“2), [49, 117, 122, 123] a tantalizing opportunity arises to forge novel pathways in the harmonisation of treatment strategies.”
BackgroundLi, L., Pan, M., Pan, S., Li, W., Zhong, Y., Hu, J., & Nie, S. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110937 · Cited by 122
Aras, M., Tchang, B. G., & Pape, J. (2021) · Nursing Clinics of North America · doi:10.1016/j.cnur.2021.07.008 · Cited by 108
Obermayer, A. M., Tripolt, N. J., Pferschy, P. N., Kojzar, H., Aziz, F., Müller, A., Schauer, M., Oulhaj, A., Aberer, F., Sourij, C., et al. (2022) · Diabetes Care · doi:10.2337/dc22-1622 · Cited by 135
“Hypertension 39 (85) 18 (75) 21 (96) Heart failure 5 (11) 1 (4) 4 (18) Coronary artery disease 12 (26) 6 (25) 6 (27) History of myocardial infarction 10 (22) 3 (13) 7 (32) History of stroke 2 (4) 2 (8) 0 (0) Retinopathy 10 (22) 5 (21) 5 (23) Polyneuropathy 18 (39) 11 (46) 7 (32) Amputation 2 (4) 1 (4) 1 (5) Hyperlipid…”
BackgroundArtificial intelligence for diabetes care: current and future prospects
Sheng, B., Pushpanathan, K., Guan, Z., Lim, Q. H., Lim, Z. W., Yew, S. M. E., Goh, J. H. L., Bee, Y. M., Sabanayagam, C., Sevdalis, N., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00154-2 · Cited by 106
Ebbeling, C. B., Knapp, A., Johnson, A., Wong, J. M., Greco, K. F., Ma, C., Mora, S., & Ludwig, D. S. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab287 · Cited by 104
“Low-carbohydrate diets, with saturated fat content far exceeding current guidelines, have become popular for diabetes management (7) based on preliminary evidence of efficacy (8, 9), albeit with concern for the potential of saturated fat to raise LDL cholesterol and consequently CVD risk.”
BackgroundJing, T., Zhang, S., Bai, M., Chen, Z., Gao, S., Li, S., & Zhang, J. (2023) · Nutrients · doi:10.3390/nu15143156 · Cited by 141
“There is some controversy surrounding the ketogenic diet, but recently, the ADA included the use of the ketogenic diet as a viable therapeutic option for the treatment of T2DM patients [19].”
BackgroundAnnevelink, C. E., Sapp, P. A., Petersen, K. S., Shearer, G. C., & Kris‐Etherton, P. M. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.07.005 · Cited by 119
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Su, J., Luo, Y., Hu, S., Tang, L., & Ouyang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713381 · Cited by 127
“Excessive fiber intake can lead to belly bloating and diarrhea; abstainers have a higher prevalence of the disease than moderate drinkers; and indiscriminate combinations and large stacks of macronutrients are counterproductive [161].”
BackgroundNutritional Challenges in Metabolic Syndrome
Hoyas, I., & Leon-Sanz, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091301 · Cited by 95
“However, they recognize that there is no definitive evidence for recommending an ideal amount of protein in relation either to glycemic control or for improving CVD risk factors [49].”
BackgroundBajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s005 · Cited by 277
Vinciguerra, F., Graziano, M., Hagnäs, M. P., Frittitta, L., & Tumminia, A. (2020) · Nutrients · doi:10.3390/nu12041019 · Cited by 98
The Importance of Nutrition as a Lifestyle Factor in Chronic Pain Management: A Narrative Review
Elma, Ö., Brain, K., & Dong, H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195950 · Cited by 105
Thomsen, M. N., Skytte, M. J., Samkani, A., Carl, M. H., Weber, P., Astrup, A., Chabanova, E., Fenger, M., Frystyk, J., Hartmann, B., et al. (2022) · Diabetologia · doi:10.1007/s00125-021-05628-8 · Cited by 90
“[8] on the efficacy of carbohydrate restriction remain ambiguous.”
BackgroundInfluentialRafiullah, M., Musambil, M., & David, S. K. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab040 · Cited by 86
Zhang, N., Liu, X., Wang, L., Zhang, Y., Xiang, Y., Cai, J., Xu, H. Y., Xiao, X., & Zhao, X. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02347-3 · Cited by 107
“This association may be related to the fact that healthy lifestyle behaviors such as diet and exercise, have a direct effect on insulin sensitivity, which is a key determinant in the development of T2D [46, 47].”
BackgroundMoriconi, E., Camajani, E., Fabbri, A., Lenzi, A., & Caprio, M. (2021) · Nutrients · doi:10.3390/nu13030758 · Cited by 97
“Recently, the American Diabetes Association (ADA) included the use of VLCKD as a viable therapeutic option for the treatment of T2DM patients with obesity [17].”
BackgroundIizuka, K. (2022) · Nutrients · doi:10.3390/nu14214446 · Cited by 130
“Therefore, artificial sweeteners are included in many “sweets” and are anticipated to be a “sugar” substitute in patients with diabetes mellitus [3].”
BackgroundAutomated vs. Human Health Coaching: Exploring Participant and Practitioner Experiences
Mitchell, E. G., Maimone, R., Cassells, A. N., Tobin, J. N., Davidson, P., Smaldone, A. M., & Mamykina, L. (2021) · Proceedings of the ACM on Human-Computer Interaction · doi:10.1145/3449173 · Cited by 88
“Participants with T2D were recruited from two Federally Qualified Health Centers (FQHC) in a major United States metropolitan area.”
BackgroundInfluentialJardine, M., Kahleová, H., Levin, S., Ali, Z., Trapp, C., & Barnard, N. D. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab063 · Cited by 98
“The American Association of Clinical Endocrinologists and the American College of Endocrinology, as well as the American College of Lifestyle Medicine, recommend a plant-based eating pattern as a key component of lifestyle therapy for patients with type 2 diabetes (5, 6).”
BackgroundJakubowicz, D., Landau, Z., Tsameret, S., Wainstein, J., Raz, I., Ahren, B., Chapnik, N., Barnea, M., Ganz, T., Menaged, M., et al. (2019) · Diabetes Care · doi:10.2337/dc19-1142 · Cited by 77
“Diet intervention is a pivotal component of the medical management of diabetes (1).”
BackgroundStote, K. S., Wilson, M. M., Hallenbeck, D., Thomas, K., Rourke, J. M., Sweeney, M. I., Gottschall‐Pass, K. T., & Gosmanov, A. R. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa030 · Cited by 93
“Individuals with type 2 diabetes should consume the amount of fiber recommended by the Dietary Guidelines for Americans (minimum 14 g fiber/1000 kcal) (9, 43).”
BackgroundInfluentialUnwin, D. J., Tobin, S., Murray, S. W., Delon, C., & Brady, A. J. B. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16152680 · Cited by 90
“Restricting dietary carbohydrates is now recognised as one way to help control the international epidemic of T2D [5].”
BackgroundInfluentialEllagic Acid as a Tool to Limit the Diabetes Burden: Updated Evidence
Amor, A. J., Gómez‐Guerrero, C., Ortega, E., Sala‐Vila, A., & Lázaro, I. (2020) · Antioxidants · doi:10.3390/antiox9121226 · Cited by 81
“Despite the increasing number of pharmacological options [3], dietary intervention still remains as the cornerstone of the prevention and treatment of T2D [4].”
BackgroundMilenković, T., Bozhinovska, N., Μacut, D., Bjekić-Macut, J., Rahelić, D., Velija-Ašimi, Z., & Bureković, A. (2021) · Nutrients · doi:10.3390/nu13041307 · Cited by 119
“Nonetheless, despite this significant pharmacological improvement, the Standards of Medical Care in Diabetes 2020 by the ADA includes a separate section that focuses on lifestyle modifications that improve diabetes and, consequently, overall health [7–9].”
BackgroundInfluentialMoon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Rosenfeld, R. M., Kelly, J. H., Agarwal, M., Aspry, K., Barnett, T., Davis, B. C., Fields, D., Gaillard, T., Gulati, M., Guthrie, G. E., et al. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221087624 · Cited by 71
Diabetes and cardiovascular disease: inter-relation of risk factors and treatment
Sharma, A., Mittal, S., Aggarwal, R., & Chauhan, M. K. (2020) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-020-00151-w · Cited by 100
“It also involves the creation of individualized action plans to foster and acknowledge self-care [189].”
BackgroundLifestyle Intervention Strategy to Treat Diabetes in Older Adults: A Randomized Controlled Trial
Celli, A., Barnouin, Y., Jiang, B. C., Blevins, D., Colleluori, G., Mediwala, S. N., Armamento‐Villareal, R., Qualls, C., & Villareal, D. T. (2022) · Diabetes Care · doi:10.2337/dc22-0338 · Cited by 93
Continuous Glucose Monitoring As a Behavior Modification Tool
Ehrhardt, N., & Al Zaghal, E. (2020) · Clinical Diabetes · doi:10.2337/cd19-0037 · Cited by 69
“The ADA no longer recommends specific totalmeal or daily carbohydrate intake levels, and there aremixedmessages about low-GIdiets (17).”
BackgroundSharma, S. V., McWhorter, J. W., Chow, J., Danho, M. P., Weston, S. R., Chavez, F., Moore, L. S., Almohamad, M., Gonzalez, J., Liew, E., et al. (2021) · Nutrients · doi:10.3390/nu13124492 · Cited by 71
“Culinary medicine adds to current nutrition interventions by incorporating both the practical hands-on preparation and pleasure of food and the scientific knowledge of how nutrition and dietary patterns affect health, especially diabetes prevention [15,16].”
BackgroundEmbracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes
Forouhi, N. G. (2023) · Diabetologia · doi:10.1007/s00125-023-05873-z · Cited by 98
“individualized assessment of current eating patterns, preferences, and metabolic goals’ [15].”
BackgroundResultInfluentialRitchie, N. D., Baucom, K. J., & Sauder, K. A. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s218334 · Cited by 77
Digesting the complex metabolic effects of diet on the host and microbiome
Carmody, R. N., Varady, K. A., & Turnbaugh, P. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.032 · Cited by 81
Metadata
- Authors
- Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., Saslow, L., Uelmen, S., Urbanski, P. B., & Yancy, W. S.
- Affiliations
- University of Washington (US)
- Oklahoma City Indian Clinic, Oklahoma City, OK
- Stanford Medicine (US)
- University of Alabama at Birmingham (US)
- Joslin Diabetes Center (US)
- Companion Medical, Inc., Columbia, MD
- Simple Concepts Consulting, Bellevue, WA
- Vida Health, San Francisco, CA
- American Diabetes Association (US)
- University of Michigan (US)
- St. Luke's Hospital (US)
- Duke Medical Center (US)
- Corresponding author
- Yancy, William S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-04-15
- Volume
- 42
- Issue
- 5
- Pages
- 731-754
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7011201
- OpenAlex
- W2939377558
- Semantic Scholar
- f67582ed7e2a1e7e3895735e8456bccf6537a361
- Cited by
- 1,496
- References
- 366
- Citations by year
- 2026: 168 · 2025: 258 · 2024: 266 · 2023: 211 · 2022: 204 · 2021: 198 · 2020: 149 · 2019: 36
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Pfizer
- Sanofi
- Gilead Sciences
- Harvard T.H. Chan School of Public Health
- Kowa Company
- Academy of Nutrition and Dietetics
- Novo Nordisk
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK107456, P30DK092926, P30DK020572, P30DK116074, P30DK056336, P30DK079626)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Nursing › Nutrition and Dietetics › Dietetics, Nutrition, and Education
- Keywords
- medical nutrition therapy, diabetes mellitus, prediabetes, nutrition counseling, glycemic control, weight management, cardiovascular risk factors, dietary habits, food choice, type 1 diabetes, type 2 diabetes, comorbidities, cost-effectiveness, diabetes prevention, American Diabetes Association recommendations, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.